BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6175629)

  • 1. Interactions of COOH-terminal fragments of cholecystokinin with receptors on dispersed acini from guinea pig pancreas.
    Jensen RT; Lemp GF; Gardner JD
    J Biol Chem; 1982 May; 257(10):5554-9. PubMed ID: 6175629
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of CCK-tetrapeptide analogues as potent and selective CCK-A receptor agonists.
    Shiosaki K; Lin CW; Kopecka H; Craig R; Wagenaar FL; Bianchi B; Miller T; Witte D; Nadzan AM
    J Med Chem; 1990 Nov; 33(11):2950-2. PubMed ID: 1700123
    [No Abstract]   [Full Text] [Related]  

  • 3. CCK4 contains the full hormonal information of cholecystokinin in isolated pancreatic acini.
    Sankaran H; Bailey AC; Willaims JA
    Biochem Biophys Res Commun; 1981 Dec; 103(4):1356-62. PubMed ID: 6174128
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholecystokinin-27-32-amide. A member of a new class of cholecystokinin receptor antagonists.
    Spanarkel M; Martinez J; Briet C; Jensen RT; Gardner JD
    J Biol Chem; 1983 Jun; 258(11):6746-9. PubMed ID: 6304053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actions of derivatives of cyclic nucleotides on dispersed acini from guinea pig pancreas. Discovery of a competitive antagonist of the action of cholecystokinin.
    Peikin SR; Costenbader CL; Gardner JD
    J Biol Chem; 1979 Jun; 254(12):5321-7. PubMed ID: 221466
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of sulfate ester in influencing biologic activity of cholecystokinin-related peptides.
    Vinayek R; Jensen RT; Gardner JD
    Am J Physiol; 1987 Feb; 252(2 Pt 1):G178-81. PubMed ID: 2435164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a cholecystokinin analogue with partial agonist activity.
    Howard JM; Knight M; Jensen RT; Gardner JD
    Am J Physiol; 1984 Sep; 247(3 Pt 1):G261-4. PubMed ID: 6206732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological activity of some partially modified retro-inverso analogues of cholecystokinin.
    Rodriguez M; Galas MC; Lignon MF; Mendre C; Laur J; Aumelas A; Martinez J
    J Med Chem; 1989 Oct; 32(10):2331-9. PubMed ID: 2477546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional cholecystokinin receptors are distinguished kinetically by biotinyl-Tyr-Gly-(Thr28,Nle31)CCK(25-33) in rat pancreatic acini.
    Winand J; Poloczek P; Delporte C; Moroder L; Svoboda M; Christophe J
    Biochim Biophys Acta; 1991 Oct; 1080(2):181-90. PubMed ID: 1718434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of receptors for gastrin and CCK on gastric smooth muscle cells.
    Menozzi D; Gardner JD; Jensen RT; Maton PN
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G73-9. PubMed ID: 2473654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cholecystokinin variant (CCK39) on dispersed acinar cells from guinea pig pancreas.
    Sjodin L; Gardner JD
    Gastroenterology; 1977 Nov; 73(5):1015-8. PubMed ID: 198332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norepinephrine stimulates amylase release from pancreatic acini.
    Joehl RJ; Rose RC; Nahrwold DL
    J Surg Res; 1983 Jun; 34(6):543-9. PubMed ID: 6190041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural requirements for action of cholecystokinin on enzyme secretion from pancreatic acini.
    Villanueva ML; Collins SM; Jensen RT; Gardner JD
    Am J Physiol; 1982 Apr; 242(4):G416-22. PubMed ID: 6175230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecystokinin octa- and tetrapeptide degradation by synaptic membranes. I. Evidence for competition with enkephalins for in vitro common degradation pathways.
    Deschodt-Lanckman M; Bui ND
    Peptides; 1981; 2 Suppl 2():113-8. PubMed ID: 6283489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.
    Rodriguez M; Lignon MF; Galas MC; Fulcrand P; Mendre C; Aumelas A; Laur J; Martinez J
    J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal fragments of CCK-(26-33) as cholecystokinin receptor antagonists in guinea pig pancreatic acini.
    Gardner JD; Knight M; Sutliff VE; Jensen RT
    Am J Physiol; 1985 Jan; 248(1 Pt 1):G98-102. PubMed ID: 2578257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin-induced residual stimulation of enzyme secretion from mouse pancreatic acini.
    Younes M; Jensen RT; Gardner JD
    Biochim Biophys Acta; 1987 Oct; 930(3):410-8. PubMed ID: 2443185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory capacity of isolated pancreatic acinar cells.
    Kaufman ME; Grand RJ
    Pediatr Res; 1978 Apr; 12(4 Pt 1):288-92. PubMed ID: 652409
    [No Abstract]   [Full Text] [Related]  

  • 19. Distinct activation of Na+-H+ exchange by gastrin and CCK peptide in acini from guinea pig.
    Bastie MJ; Delvaux M; Dufresne M; Saunier-Blache JS; Vaysse N; Ribet A
    Am J Physiol; 1988 Jan; 254(1 Pt 1):G25-32. PubMed ID: 2447799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COOH-terminal fragments of cholecystokinin. A new class of cholecystokinin receptor antagonists.
    Jensen RT; Jones SW; Gardner JD
    Biochim Biophys Acta; 1983 May; 757(2):250-8. PubMed ID: 6189522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.